Skip to main content
. 2022 Jul 11;27(14):4430. doi: 10.3390/molecules27144430

Figure 8.

Figure 8

CC50 (concentration of the drug that reduces cell viability by 50%) and IC50 (concentration that inhibits 50% of breast cancer cells) of doxorubicin (standard drug) and extract (Mopp and MoP) comparisons toward Vero cell lines and 4T1 cell lines.